Method of stabilizing human eye tissue by reaction with nitrite and related agents such as nitro compounds
View Patent ↗A method for stabilizing collagenous eye tissues by nitrite and nitroalcohol treatment. The topical stiffening agent contains sodium nitrite or a nitroalcohol in a buffered balanced salt solution and can be applied to the surface of the eye on a daily basis for a prolonged period. Application of the solution results in progressive stabilization of the corneal and scleral tissues through non-enzymatic cross-linking of collagen fibers. The compounds can penetrate into the corneal stroma without the need to remove the corneal epithelium. In addition, ultraviolet light is not needed to activate the cross-linking process. The resulting stabilization of corneal and scleral tissues can prevent future alterations in corneal curvature and has utility in diseases such as keratoconus, keratectasia, progressive myopia, and glaucoma.
1. A method of cross-linking collagen in a collagenous tissue comprising contacting the collagenous tissue with an amount of a nitrogen oxide-containing compound effective to cross-link the collagen in the collagenous tissue, wherein the nitrogen oxide-containing compound is a β-nitro alcohol.
2. The method of claim 1 wherein the collagenous tissue is in a subject.
3. The method of claim 1 or claim 2 wherein the collagenous tissue is cornea, sclera, skin, tendon, blood vessel, heart valve, bone, cartilage or other tendinous tissue.
4. The method of claim 3 wherein the collagenous tissue is cornea.
5. The method of claim 1 wherein the collagenous tissue is human cornea.
6. The method of claim 2 wherein the collagenous tissue is cornea and the subject is afflicted with keratoconus or keratectasia.
7. The method of claim 1 wherein the β-nitro alcohol is 2-nitro-1-pentanol.
8. The method of claim 1 wherein the β-nitro alcohol is 2-nitroethanol.
9. The method of claim 1 wherein the β-nitro alcohol is 2-nitro-1-propanol.
10. The method of claim 1 wherein the β-nitro alcohol is 3-nitro-2-pentanol.
11. The method of claim 1 wherein the β-nitro alcohol is selected from the group consisting of 2-nitro-1-pentanol, 2-nitroethanol, 2-nitro-1-propanol, 3-nitro-2-pentanol and combinations thereof.
12. The method of claim 1 wherein the β-nitro alcohol is in an aqueous solution having a pH of 3 to a pH of 10.
13. The method of claim 12 wherein the β-nitro alcohol is in an aqueous solution having a pH of 7.4.
14. The method of claim 1 wherein the β-nitro alcohol is in an aqueous solution comprising sodium phosphate, potassium phosphate, dextran, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, sodium citrate dehydrate, and balance water.
15. The method of claim 1 wherein the β-nitro alcohol is in an aqueous solution comprising 0 to 20 percent sodium phosphate by weight/volume, 0 to 20 percent potassium phosphate by weight/volume, and 0 to 20 percent dextran by weight/volume.
16. The method of claim 1 wherein the β-nitro alcohol is in an aqueous solution comprising 0.64% sodium chloride by weight/volume, 0.075% potassium chloride by weight/volume, 0.048% calcium chloride dihydrate by weight/volume, 0.03% magnesium chloride hexahydrate by weight/volume, 0.39% sodium acetate trihydrate by weight/volume, 0.17% sodium citrate dehydrate by weight/volume, and balance water.
17. The method of claim 1 , wherein the β-nitro alcohol is in an aqueous solution and wherein the tonicity of the aqueous solution is from 1 milli-osmoles to 100 osmoles.
18. The method of claim 1 wherein the contacting of the β-nitro alcohol to the collagenous tissue is performed by intermittent administration of the nitrogen oxide-containing compound to the collagenous tissue for a duration of time effective to cross-link collagen.